New dye could help surgeons see and remove brain tumors more completely
NCT ID NCT07438860
Summary
This early-stage study is testing the safety of a new imaging dye called SBK2-ICG. It is given to adults with malignant brain tumors about an hour before their scheduled surgery. The goal is to see if the dye can light up the exact edges of the tumor, helping surgeons remove more of the cancer while protecting healthy brain tissue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Premier Health Neuroscience Institute
Dayton, Ohio, 45409, United States
Contact
Contact
-
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.